MAPT and neurodegenerative disease: As p-tau (especially p-tau181) is present at normal levels in most other neurodegenerative diseases, p-tau has higher sensitivity and specificity for differential diagnosis of AD and other diseases (Janelidze et al., 2020; Thijssen et al., 2020; Brickman et al., 2021).